Fitriani, N.P. and Suyata (2024) “The Role of Anti-PD 1 (Programmed Cell Death-1) (Pembrolizumab) in Hepatocellular Carcinoma: A Narrative Literature Review”, Bioscientia Medicina : Journal of Biomedicine and Translational Research, 8(4), pp. 4289–4296. doi:10.37275/bsm.v8i4.975.